{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:26:57Z","timestamp":1748374017072,"version":"3.35.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/wnn.0b013e31817d74bf","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T07:17:03Z","timestamp":1221549423000},"page":"190-195","source":"Crossref","is-referenced-by-count":2,"title":["Prominent Neuroleptic Sensitivity in a Case of Early-onset Alzheimer Disease due to Presenilin-1 G206A Mutation"],"prefix":"10.1097","volume":"21","author":[{"given":"Steven P.","family":"Cercy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archneur.60.6.884","article-title":"Presenilin 1 mutation in an African American family with atypical Alzheimer disease","volume":"60","author":"Rippon","year":"2003","journal-title":"Arch Neurol"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/01.wnl.0000171397.32851.bc","article-title":"Familial Alzheimer disease: decreases in CSF A\u03b242 levels precede cognitive decline","volume":"65","author":"Moonis","year":"2005","journal-title":"Neurology"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.286.18.2257","article-title":"A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families","volume":"286","author":"Athan","year":"2001","journal-title":"JAMA"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/brain\/123.5.894","article-title":"Alzheimer's disease due to intronic presenilin 1 (PSEN1 intron 4) mutation","volume":"123","author":"Janssen","year":"2000","journal-title":"Brain"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1212\/WNL.44.12.2300","article-title":"Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study","volume":"44","author":"Stern","year":"1994","journal-title":"Neurology"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-002-0596-7","article-title":"NACP\/\u03b1-synuclein, NAC, \u03b2-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases","volume":"104","author":"Yokota","year":"2002","journal-title":"Acta Neuropathol"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1468-1331.2004.00865.x","article-title":"New V272A presenilin 1 mutation with very early onset subcortical dementia and parkinsonism","volume":"11","author":"Jimenez-Escrig","year":"2004","journal-title":"Eur J Neurol"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.20393","article-title":"A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease","volume":"57","author":"Ishikawa","year":"2005","journal-title":"Ann Neurol"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4088\/JCP.v66n0514","article-title":"Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias","volume":"66","author":"Aarsland","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(05)78999-6","article-title":"Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease","volume":"351","author":"Ballard","year":"1998","journal-title":"Lancet"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00004714-199908000-00007","article-title":"Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics","volume":"19","author":"Caligiuri","year":"1999","journal-title":"J Clin Psychopharm"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2007.03.016","article-title":"Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study","volume":"260","author":"Wada-Isoe","year":"2007","journal-title":"J Neurol Sci"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0891988706292755","article-title":"Predicting Lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease","volume":"19","author":"Tsuang","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004019900155","article-title":"Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP17 gene mutation","volume":"100","author":"Rosenberg","year":"2000","journal-title":"Acta Neuropathol (Berl)"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1212\/01.WNL.0000150892.81839.D1","article-title":"Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease","volume":"64","author":"Tsuang","year":"2005","journal-title":"Neurology"},{"key":"R20-11-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0278-5846(02)00339-1","article-title":"\u03b1-synuclein, A\u03b2 and Alzheimer's disease","volume":"27","author":"Wirths","year":"2003","journal-title":"Prog Neuropsychopharm Biol Psychiatry"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4065\/74.8.835","article-title":"Pathways to primary neurodegenerative disease","volume":"74","author":"Hardy","year":"1999","journal-title":"Mayo Clinic Proc"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/gps.657","article-title":"Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation","volume":"17","author":"Goldman","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"R23-11-20210129","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"key":"R24-11-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0006-3223(98)00127-9","article-title":"Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease","volume":"44","author":"Piggott","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R25-11-20210129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archneur.58.3.466","article-title":"Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis","volume":"58","author":"Sweet","year":"2001","journal-title":"Arch Neurol"},{"key":"R26-11-20210129","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3565(25)13416-2","article-title":"Biochemical profile of Risperidone, a new antipsychotic","volume":"247","author":"Leysen","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R27-11-20210129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin-dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R28-11-20210129","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00213-007-0747-6","article-title":"Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial","volume":"191","author":"Naber","year":"2007","journal-title":"Psychopharmacology"},{"key":"R29-11-20210129","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","article-title":"Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees","volume":"27","author":"Klunk","year":"2007","journal-title":"J Neurosci"},{"key":"R30-11-20210129","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1523\/JNEUROSCI.15-01-00821.1995","article-title":"Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis","volume":"15","author":"Dewey","year":"1995","journal-title":"J Neurosci"},{"key":"R31-11-20210129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00019442-200008000-00008","article-title":"Effect of Nortriptyline and Paroxetine on extrapyramidal signs and symptoms","volume":"8","author":"Mamo","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"R32-11-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0925-4927(02)00087-2","article-title":"Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study","volume":"116","author":"Volkow","year":"2002","journal-title":"Psychiatry Res"},{"key":"R33-11-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.jcp.0000203200.96205.34","article-title":"Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms","volume":"26","author":"Hedenmalm","year":"2006","journal-title":"J Clin Psychopharm"},{"key":"R34-11-20210129","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.npp.1300420","article-title":"Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behaviour","volume":"29","author":"Martinez","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R35-11-20210129","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp.2005.079228","article-title":"Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder","volume":"77","author":"Potvin","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R36-11-20210129","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1212\/WNL.54.10.1965","article-title":"Incidence of and risk factors for hallucinations and delusions in patients with probable Alzheimer's disease","volume":"54","author":"Paulsen","year":"2000","journal-title":"Neurology"},{"key":"R37-11-20210129","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archneur.55.10.1335","article-title":"Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease","volume":"55","author":"Sweet","year":"1998","journal-title":"Arch Neurol"},{"key":"R38-11-20210129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/jnnp.71.6.777","article-title":"Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation","volume":"71","author":"Holmes","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R39-11-20210129","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/hmg\/7.9.1507","article-title":"5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease","volume":"7","author":"Holmes","year":"1998","journal-title":"Hum Mol Genet"},{"key":"R40-11-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.npp.1301148","article-title":"Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease","volume":"32","author":"Zdanys","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["Cognitive and Behavioral Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNN.0b013e31817d74bf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:12:41Z","timestamp":1738365161000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00146965-200809000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wnn.0b013e31817d74bf","relation":{},"ISSN":["1543-3633"],"issn-type":[{"type":"print","value":"1543-3633"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}